Aldehydes accumulated in mitochondria as risk factors to neurodegenerative diseases
线粒体中积累的醛是神经退行性疾病的危险因素
基本信息
- 批准号:12470144
- 负责人:
- 金额:$ 9.22万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2002
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is involved in ethanol metabolism by playing a major role in acetaldehyde detoxification : A polymorphism of the ALDH2 gene is specific to north Asians. Sensitivity to ethanol is highly associated with this polymorphism (ALDH2^*2 allele), which is responsible for a deficiency of ALDH2 activity. We at first show that this deficiency influences the risk for late-onset Alzheimer's disease (LOAD) by a case-control study in a Japanese population. In a comparison of 447 patients with sex, age and region-matched non-demented controls, the genotype frequency for carrying the ALDH2^*2 allele was significantly higher in the patients than in the controls (p=0.001). Next, we examined the combined effect of the ALDH2^*2 and apolipoprotein E 4 allele (APOE-e4), which has been confirmed be a risk factor for LOAD. The ALDH2^*2 allele more significantly affected frequency and onset-age in patients with APOE-e4 than without. These results indicate that the ALDH2 deficiency is a risk factor for LOAD, acting synergistically with the APOE-e allele. Next, to elucidate the molecular mechanism involved, we obtained ALDH2-deficient cell lines by introducing mouse mutant Aldh2 cDNA into PC12 cells. We speculate that ALDH2 may function to oxidize toxic aldehyde derivatives. Then, we found that the ALDH2-deficient transfectants were highly vulnerable to exogenous 4-hydroxy-2-nonenal, an aldehyde derivative generated from peroxidized fatty acids. In addition, the ALDH2-deficient transfectants were sensitive to oxidative insult induced by antimycin A, accompanied by an accumulation of proteins modified with 4-hydroxy-2-nonenal. Mitochondrial ALDH2 functions as a protector against oxidative stress.
线粒体醛脱氢酶2(ALDH 2)通过在乙醛解毒中发挥主要作用而参与乙醇代谢:ALDH 2基因的多态性是北亚人特有的。对乙醇的敏感性与这种多态性(ALDH 2 ^*2等位基因)高度相关,这是导致ALDH 2活性缺乏的原因。我们首先表明,这种缺陷影响晚发性阿尔茨海默病(LOAD)的风险,在日本人口的病例对照研究。将447名患者与性别、年龄和地区匹配的非痴呆对照组进行比较,发现患者携带ALDH 2 ^*2等位基因的基因型频率显著高于对照组(p=0.001)。接下来,我们检测了ALDH 2 ^*2和载脂蛋白E4等位基因(APOE-e4)的联合作用,这已被证实是LOAD的一个危险因素。ALDH 2 ^*2等位基因对APOE-e4患者的发病频率和发病年龄的影响比无APOE-e4患者更显著。这些结果表明,ALDH 2缺乏是LOAD的危险因素,与APOE-e等位基因协同作用。接下来,为了阐明所涉及的分子机制,我们通过将小鼠突变体Aldh 2 cDNA导入PC 12细胞获得了ALDH 2缺陷细胞系。我们推测ALDH 2可能具有氧化有毒醛衍生物的功能。然后,我们发现ALDH 2缺陷的转染子非常容易受到外源性4-羟基-2-壬烯醛的影响,4-羟基-2-壬烯醛是由过氧化脂肪酸产生的醛衍生物。此外,ALDH 2缺陷型转染子对抗霉素A诱导的氧化损伤敏感,伴随着用4-羟基-2-壬烯醛修饰的蛋白质的积累。线粒体ALDH 2作为抗氧化应激的保护剂发挥作用。
项目成果
期刊论文数量(88)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kanamori, T., et al.: "Truncated product of the bifunctional DLST gene involved in biogenesis of the respiratory chain."The EMBO J.. 22. 2913-2923 (2003)
Kanamori, T. 等人:“参与呼吸链生物发生的双功能 DLST 基因的截短产物。”EMBO J.. 22. 2913-2923 (2003)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nomiyama, T.: "Accumulates a Somatic Mutation in Mitochondrial DNA extracted from peripheral blood cells in diabetic patients"Diabetologia.. 45. 1577-1583 (2002)
Nomiyama, T.:“从糖尿病患者外周血细胞中提取的线粒体 DNA 中积累体细胞突变”Diabetologia.. 45. 1577-1583 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ohsawa, I.: "Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells"J. Neurochem.. 84. 1110-1117 (2003)
Ohsawa, I.:“线粒体醛脱氢酶的缺乏会增加 PC12 细胞对氧化应激的脆弱性”J.
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
太田成男: "ミトコンドリア異常とその意義"ALDH2遺伝子の関連解析. 40. 87-89 (2001)
N. Ota:“线粒体异常及其意义” ALDH2 基因关联分析。40. 87-89 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
太田成男: "新ミトコンドリア学"ミトコンドリアRNAとタンパク質の合成. 5 (2001)
Shigeo Ota:《新线粒体学》线粒体 RNA 和蛋白质的合成 5 (2001)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OHTA Shigeo其他文献
OHTA Shigeo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OHTA Shigeo', 18)}}的其他基金
Protective effects of hydrogen against irradiation
氢气对辐射的防护作用
- 批准号:
24651055 - 财政年份:2012
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Preventive effects of geriatric and life-style related diseases by oral administration of a novel hydrogen-producing material
口服新型产氢材料对老年和生活方式相关疾病的预防作用
- 批准号:
23300257 - 财政年份:2011
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development toward preventive application of molecular hydrogen with a novel concept for lifestyle-related diseases
以新概念开发分子氢预防性应用,治疗生活方式相关疾病
- 批准号:
20300230 - 财政年份:2008
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a novel therapy for brain infarction using a cell-penetrating protein exhibiting enhanced anti-cell death activity
使用具有增强抗细胞死亡活性的细胞穿透蛋白开发脑梗塞新疗法
- 批准号:
16390257 - 财政年份:2004
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The molecular basis of the higher function of RNA molecules
RNA分子高级功能的分子基础
- 批准号:
09278104 - 财政年份:1997
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
STUDIES ON THE DEVELOPMENT OF METHODS TO REMOVE THE MUTANT MITOCHONDRIAL GENOME FOR THERAPY OF MITOCHONDRIAL DESEASE
开发去除突变线粒体基因组用于治疗线粒体疾病的方法的研究
- 批准号:
08457196 - 财政年份:1996
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Pathology on Mitochondrial Encepholomyopathy
线粒体脑肌病的分子病理学
- 批准号:
04670151 - 财政年份:1992
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Construction of transgenic mice into which mutant mitochondrial DNA is artificially introduced.
人工引入突变线粒体 DNA 的转基因小鼠的构建。
- 批准号:
04557012 - 财政年份:1992
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Cloning Regulatory Genes for Proliferation of Mitochondria and Effects on Mitochondrial Disease
克隆线粒体增殖调控基因及其对线粒体疾病的影响
- 批准号:
01570141 - 财政年份:1989
- 资助金额:
$ 9.22万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Cerebrovascular mitochondria as mediators of neuroinflammation in Alzheimer's Disease
脑血管线粒体作为阿尔茨海默病神经炎症的介质
- 批准号:
10723580 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
DNA methylation signatures of Alzheimer's disease in aged astrocytes
老年星形胶质细胞中阿尔茨海默病的 DNA 甲基化特征
- 批准号:
10807864 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
The Role of Viral Exposure and Age in Alzheimer's Disease Progression
病毒暴露和年龄在阿尔茨海默病进展中的作用
- 批准号:
10717223 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
Energy expenditure, cognitive function, and biomarker features of Alzheimer's disease
阿尔茨海默病的能量消耗、认知功能和生物标志物特征
- 批准号:
10572262 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
Role of mitochondrial GDAP1 in Alzheimer's disease
线粒体 GDAP1 在阿尔茨海默病中的作用
- 批准号:
10739858 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
Feasibility of Improving Glycemia to Prevent Alzheimer's Disease
改善血糖预防阿尔茨海默病的可行性
- 批准号:
10633688 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
Role of Mettl3-dependent RNA m6A dysregulation in Alzheimer's disease
Mettl3 依赖性 RNA m6A 失调在阿尔茨海默病中的作用
- 批准号:
10739065 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
Novel Early Retinal Imaging Biomarkers for Treating Later Spatial Memory Loss in Experimental Alzheimer's Disease
用于治疗实验性阿尔茨海默病后期空间记忆丧失的新型早期视网膜成像生物标志物
- 批准号:
10650636 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
ADVANCED COMPREHENSIVE MAGNETIC RESONANCE SOLUTION FOR THE NONINVASIVE CHARACTERIZATION OF HIGH RESOLUTION METABOLIC BIOMARKERS OF RISK IN PATIENTS WITH ALZHEIMER'S DISEASE AND DEMENTIA
先进的综合磁共振解决方案,用于无创表征阿尔茨海默病和痴呆症患者风险的高分辨率代谢生物标志物
- 批准号:
10820517 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:
The Role of MICU3 in Alzheimer's Disease Pathogenesis
MICU3 在阿尔茨海默病发病机制中的作用
- 批准号:
10677454 - 财政年份:2023
- 资助金额:
$ 9.22万 - 项目类别:














{{item.name}}会员




